Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00560937 · ClinicalTrials.gov registry record · NA

Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia

A NA study of Schizophrenia, sponsored by Durham VA Medical Center.

Completed
Registry status
NA
Development phase
28
Enrollment target
1
Study location

NCT00560937 is a NA study of Schizophrenia that has completed, run by Durham VA Medical Center. The registered enrollment target is 28 participants, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (87% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00560937, a NA study of Schizophrenia, has completed, sponsored by Durham VA Medical Center.

COMPLETED
Registry status
NA
Development phase
28 participants
Enrollment target
1
Study location

Study Summary

This is a pilot study of pregnenolone as an augmentation treatment for schizophrenia. The goal of this placebo-controlled study is to provide preliminary efficacy data for potential pregnenolone effects on cognitive symptoms and negative symptoms in patients with schizophrenia. Depressive symptoms and positive symptoms will also be assessed.

Conditions Studied

Schizophrenia

Interventions

  • DRUG Placebo
  • DRUG Pregnenolone

Study Locations (1)

North Carolina

  • Durham VAMC - Durham

Trial Details

FieldValue
Enrollment Target 28 participants
Start Date 2005-06
Est. Completion 2008-04
Phase NA

Sponsor

Durham VA Medical Center

17 total trials

Interested in This Trial?

Full Details on ClinicalTrials.gov ↗

What the Registry Record Tells You About NCT00560937

The ClinicalTrials.gov registry entry for NCT00560937 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 28 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 219-participant average among 315 other Schizophrenia trials with a reported enrollment target (87% lower). The listed sponsor is Durham VA Medical Center, which has 17 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Schizophrenia appearing as the primary indexed condition, and to 2 interventions - of which Placebo is the first listed.

NCT00560937 reports 1 study location spanning 1 distinct geographic area - top geographies include North Carolina.

Frequently Asked Questions

What is clinical trial NCT00560937 about?

NCT00560937 is a clinical study titled "Pilot Study of Pregnenolone Augmentation Targeting Cognitive Symptoms in Persistently Symptomatic Patients With Schizophrenia". This is a pilot study of pregnenolone as an augmentation treatment for schizophrenia. The goal of this placebo-controlled study is to provide preliminary efficacy data for potential pregnenolone effects on cognitive symptoms and negative symptoms in patients with schizophrenia. Depressive symptoms a...

What is the current status of trial NCT00560937?

This trial is currently completed. It is a NA study. The enrollment target is 28 participants. The study started on 2005-06. Estimated completion is 2008-04.

What conditions does trial NCT00560937 study?

This clinical trial studies the following conditions: Schizophrenia.

What interventions are being tested in trial NCT00560937?

The interventions under investigation include: Placebo (DRUG), Pregnenolone (DRUG).

Who is sponsoring clinical trial NCT00560937?

This trial is sponsored by Durham VA Medical Center, which has 17 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00560937 being conducted?

This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Learn More About Clinical Trials

Similar trials for Schizophrenia

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Explore more on PlainTrial

Schizophrenia

All registered trials for this condition

North Carolina

All trials with a study site in North Carolina

Recruiting now

Find trials open to new participants near you

Rankings

Top sponsors, conditions, and phases

Read our methodology - how this data is sourced, computed, and verified.

Related

Browse all → | Rankings →
Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.